Search Results - "Abronina, I. F."

Refine Results
  1. 1

    Treatment with interleukin-2 in an immunodepressed state by Bykovskaya, S N, Abronina, I F, Kypriyanova, T A, Malachova, N V

    Published in Biomedicine & pharmacotherapy (1990)
    “…Cytotoxic T-lymphocyte (CTL) and lymphokine activated killer (LAK) cell (fraction II) precursors with a density of 1.077-1.067 g/ml and suppressor cells…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Requirements for induction of specific suppressor T cells and detection of their H-2 antigen-binding receptors by fractionation on target cell monolayers by Brondz, B D, Karaulov, A V, Abronina, I F, Blandova, Z K

    Published in Scandinavian journal of immunology (01-01-1981)
    “…The MC-resistant specific suppressor T cells that inhibit DNA synthesis and CTL generation in MLC were induced in vivo by gamma-irradiated allogeneic lymphoid…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Inactivation of specific anti-H-2 suppressor T cells by antisera to I-J and I-C subregion products of the H-2 complex by Brondz, B D, Zaiceva, M B, Abronina, I F, Blandova, Z K

    Published in Journal of immunogenetics (01-12-1983)
    “…Two antisera to Ia antigens, products of the H-2 complex I-Cd and I-JkEk subregions, respectively, have been obtained by immunization of the F1 hybrids of…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Down-regulation of LAK cell-mediated cytotoxicity: cancer and ageing by Bykovskaya, S N, Abronina, I F, Kupriyanova, T A, Bubenik, J

    Published in Biomedicine & pharmacotherapy (1990)
    “…A comparative study was made of the generation of lymphokine-activated killer (LAK) cells in patients with melanoma and healthy donors of different age groups…”
    Get more information
    Journal Article
  8. 8

    The influence of tumor immunity suppressors on the effector stage of human and animal lymphokine-activated killer cells by Abronina, I F, Indrova, M, Bubenic, J, Figurin, K M, Malakhova, N V, Bykovskaya, S N

    Published in Biomedicine & pharmacotherapy (1993)
    “…Spleen cells of tumor-bearing mice suppressed the cytolytic activity of syngeneic LAK cells when added to the mixture of LAK cells and target cells at the…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Use of heat shock of antigen-presenting cells for functional testing of allospecificity memory T-cells by Kazanskiĭ, D B, Petrishchev, V N, Shtil', A A, Chernysheva, A D, Sernova, N V, Abronina, I F, Pobezinskiĭ, L A, Agafonova, E L

    Published in Bioorganicheskaia khimiia (01-02-1999)
    “…For many years, the search for the appropriate method of testing the functional activity of the memory T-cells was an urgent problem and determined progress in…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Conditions for antitumor cytotoxic T-lymphocyte formation and inhibition of their activity by T-suppressors in mixed culture of human lymphocytes and tumor cells by Abronina, I F, Anan'ev, V S

    “…Conditions for antitumour autolytic T lymphocytes (CTL) induction during human mixed lymphocyte tumour cell culturing (MLTC), as well as the patterns of CTL…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18

    The beta-carotene stimulation of cellular immunity reactions in mice by Abronina, I F, Ramanauskaĭte, R Iu, Andreĭchuk, T N, Rytenko, A N, Korostelev, S A

    “…The immunomodulating properties of synthetic beta-carotene were studied in C57Bl/6 and BALB/c mice using the tests of proliferative, cytotoxic and suppressor…”
    Get more information
    Journal Article
  19. 19

    The effect of a clover extract on the proliferation of human and murine lymphocytes in vitro by Babaskin, V S, Kiselevskiĭ, M V, Abronina, I F, Efimov, S A, Bykovskaia, S N

    “…The extracts were prepared from meadow clover harvested at the stages of blossoming and budding. The major biological activity of such extracts is represented…”
    Get more information
    Journal Article
  20. 20